{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:57:57Z","timestamp":1784329077083,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.amjmed.2020.10.017","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T12:40:51Z","timestamp":1604925651000},"page":"672-681.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Intensity of Guideline-Directed Medical Therapy for Coronary Heart Disease and Ischemic Heart Failure Outcomes"],"prefix":"10.1016","volume":"134","author":[{"given":"Rebecca","family":"Crosier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis T.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick R.","family":"Lawler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9283-8764","authenticated-orcid":false,"given":"Therese A.","family":"Stukel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Farkouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2839-2611","authenticated-orcid":false,"given":"John A.","family":"Spertus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather J.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7078-745X","authenticated-orcid":false,"given":"Douglas S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.amjmed.2020.10.017_bib0001","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics-2019 update: a report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.amjmed.2020.10.017_bib0002","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0735-1097(00)00582-9","article-title":"Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study","volume":"35","author":"Gottdiener","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.amjmed.2020.10.017_bib0003","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/CIRCHEARTFAILURE.111.964791","article-title":"Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure","volume":"5","author":"Chun","year":"2012","journal-title":"Circ Heart Fail"},{"issue":"3","key":"10.1016\/j.amjmed.2020.10.017_bib0004","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cardfail.2004.08.160","article-title":"Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry","volume":"11","author":"O'Connor","year":"2005","journal-title":"J Card Fail"},{"issue":"12","key":"10.1016\/j.amjmed.2020.10.017_bib0005","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.amjmed.2020.10.017_bib0006","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1100171","article-title":"Effect of nesiritide in patients with acute decompensated heart failure","volume":"365","author":"O'Connor","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.amjmed.2020.10.017_bib0007","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.amjmed.2020.10.017_bib0008","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.jacc.2005.11.073","article-title":"Angiotensin-converting enzyme inhibitors in coronary artery disease and preserved left ventricular systolic function: a systematic review and meta-analysis of randomized controlled trials","volume":"47","author":"Al-Mallah","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.amjmed.2020.10.017_bib0009","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/0003-4819-147-1-200707030-00003","article-title":"Beta-blockers and progression of coronary atherosclerosis: pooled analysis of 4 intravascular ultrasonography trials","volume":"147","author":"Sipahi","year":"2007","journal-title":"Ann Intern Med"},{"issue":"24","key":"10.1016\/j.amjmed.2020.10.017_bib0010","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.282.24.2340","article-title":"Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials","volume":"282","author":"LaRosa","year":"1999","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.amjmed.2020.10.017_bib0011","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1001\/archinte.162.19.2197","article-title":"Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events","volume":"162","author":"Weisman","year":"2002","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.amjmed.2020.10.017_bib0012","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"January","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.amjmed.2020.10.017_bib0013","first-page":"837","article-title":"Canadian Cardiovascular Society guidelines for the diagnosis and management of stable ischemic heart disease","volume":"30","author":"Mancini","year":"2014","journal-title":"Can J Cardiol"},{"issue":"Suppl A","key":"10.1016\/j.amjmed.2020.10.017_bib0014","first-page":"S387","article-title":"Assessment and management of acute coronary syndromes (ACS): a Canadian perspective on current guideline-recommended treatment\u2013part 1: non-ST-segment elevation ACS","volume":"27","author":"Fitchett","year":"2011","journal-title":"Can J Cardiol"},{"issue":"25","key":"10.1016\/j.amjmed.2020.10.017_bib0015","first-page":"e354","volume":"126","author":"Fihn","year":"2012","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.amjmed.2020.10.017_bib0016","first-page":"e344","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"issue":"38","key":"10.1016\/j.amjmed.2020.10.017_bib0017","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Montalescot","year":"2013","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.amjmed.2020.10.017_bib0018","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.amjmed.2020.10.017_bib0019","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cjco.2020.02.007","article-title":"Comparison of troponin elevation, prior myocardial infarction, and chest pain in acute ischemic heart failure","volume":"2","author":"Freitas","year":"2020","journal-title":"CJC Open"},{"issue":"8","key":"10.1016\/j.amjmed.2020.10.017_bib0020","doi-asserted-by":"crossref","first-page":"e23065","DOI":"10.1371\/journal.pone.0023065","article-title":"Prediction of emergent heart failure death by semi-quantitative triage risk stratification","volume":"6","author":"Van Spall","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.amjmed.2020.10.017_bib0021","first-page":"1038.e5","article-title":"Canadian Cardiovascular Society quality indicators for heart failure","volume":"32","author":"McKelvie","year":"2016","journal-title":"Can J Cardiol"},{"issue":"1","key":"10.1016\/j.amjmed.2020.10.017_bib0022","first-page":"38","article-title":"CCORT\/CCS quality indicators for acute myocardial infarction care","volume":"19","author":"Tran","year":"2003","journal-title":"Can J Cardiol"},{"issue":"28","key":"10.1016\/j.amjmed.2020.10.017_bib0023","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"issue":"16","key":"10.1016\/j.amjmed.2020.10.017_bib0024","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1002\/sim.5705","article-title":"The performance of different propensity score methods for estimating marginal hazard ratios","volume":"32","author":"Austin","year":"2013","journal-title":"Stat Med"},{"issue":"19","key":"10.1016\/j.amjmed.2020.10.017_bib0025","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1001\/jama.290.19.2581","article-title":"Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model","volume":"290","author":"Lee","year":"2003","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.amjmed.2020.10.017_bib0026","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1161\/CIRCULATIONAHA.118.035509","article-title":"prospective validation of the emergency heart failure mortality risk grade for acute heart failure","volume":"139","author":"Lee","year":"2019","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.amjmed.2020.10.017_bib0027","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1161\/CIRCULATIONAHA.115.014281","article-title":"Medication initiation burden required to comply with heart failure guideline recommendations and hospital quality measures","volume":"132","author":"Allen","year":"2015","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.amjmed.2020.10.017_bib0028","doi-asserted-by":"crossref","first-page":"e1008","DOI":"10.1016\/S2214-109X(18)30306-1","article-title":"Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study","volume":"6","author":"Teng","year":"2018","journal-title":"Lancet Glob Health"},{"issue":"10","key":"10.1016\/j.amjmed.2020.10.017_bib0029","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jama.294.10.1240","article-title":"Risk-treatment mismatch in the pharmacotherapy of heart failure","volume":"294","author":"Lee","year":"2005","journal-title":"JAMA"},{"issue":"48","key":"10.1016\/j.amjmed.2020.10.017_bib0030","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1093\/eurheartj\/ehu342","article-title":"Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)","volume":"35","author":"Badar","year":"2014","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.amjmed.2020.10.017_bib0031","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jacc.2017.11.068","article-title":"Compliance with guideline-directed medical therapy in contemporary coronary revascularization trials","volume":"71","author":"Pinho-Gomes","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.amjmed.2020.10.017_bib0032","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1056\/NEJMoa0706201","article-title":"Rosuvastatin in older patients with systolic heart failure","volume":"357","author":"Kjekshus","year":"2007","journal-title":"N Engl J Med"},{"issue":"9645","key":"10.1016\/j.amjmed.2020.10.017_bib0033","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(08)61240-4","article-title":"Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Tavazzi","year":"2008","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.amjmed.2020.10.017_bib0034","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1056\/NEJMoa1808848","article-title":"Rivaroxaban in patients with heart failure, sinus rhythm, and coronary disease","volume":"379","author":"Zannad","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2020.10.017_bib0035","series-title":"Advisory committee briefing document: ATLAS ACS 2 TIMI 51","year":"2012"},{"issue":"13","key":"10.1016\/j.amjmed.2020.10.017_bib0036","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jama.2012.12559","article-title":"Beta-blocker use and clinical outcomes in stable outpatients with and without coronary artery disease","volume":"308","author":"Bangalore","year":"2012","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.amjmed.2020.10.017_bib0037","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1161\/CIRCHEARTFAILURE.112.000075","article-title":"Outcomes and care of patients with acute heart failure syndromes and cardiac troponin elevation","volume":"6","author":"Braga","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"24","key":"10.1016\/j.amjmed.2020.10.017_bib0038","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1161\/CIRCULATIONAHA.108.815944","article-title":"Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the Framingham Heart Study of the national heart, lung, and blood institute","volume":"119","author":"Lee","year":"2009","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.amjmed.2020.10.017_bib0039","first-page":"1342","article-title":"2017 Comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure","volume":"33","author":"Ezekowitz","year":"2017","journal-title":"Can J Cardiol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934320309578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934320309578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:22:39Z","timestamp":1757582559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934320309578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0002934320309578"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2020.10.017","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intensity of Guideline-Directed Medical Therapy for Coronary Heart Disease and Ischemic Heart Failure Outcomes","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2020.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}